• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    Azathioprine therapy selectively ablates human V delta 2(+) T cells in Crohn's disease 
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Azathioprine therapy selectively ablates human V delta 2(+) T cells in Crohn's disease
    •   QMRO Home
    • Blizard Institute
    • Centre for Immunobiology
    • Azathioprine therapy selectively ablates human V delta 2(+) T cells in Crohn's disease
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    Azathioprine therapy selectively ablates human V delta 2(+) T cells in Crohn's disease

    View/Open
    Published version (1.108Mb)
    Volume
    125
    Pagination
    3215 - 3225
    DOI
    10.1172/JCI80840
    Journal
    JOURNAL OF CLINICAL INVESTIGATION
    Issue
    8
    ISSN
    0021-9738
    Metadata
    Show full item record
    Authors
    McCarthy, NE; Hedin, CR; Sanders, TJ; Amon, P; Hoti, I; Ayada, I; Baji, V; Giles, EM; Wildemann, M; Bashir, Z
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/14670
    Collections
    • Centre for Immunobiology [921]
    Licence information
    Authors retain rights to present the work without prior permission in original, revised, adapted, or derivative form, provided that all such use is for personal or nonprofit. Commercial use and reproduction is restricted under this agreement
    Copyright statements
    2015.JCI
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.